|
ATP2A2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.952000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.031800E-04 |
| Normal-vs-Stage2 |
3.896200E-01 |
| Normal-vs-Stage3 |
9.679800E-03 |
| Normal-vs-Stage4 |
8.840700E-03 |
| Stage1-vs-Stage2 |
7.594400E-02 |
| Stage1-vs-Stage3 |
7.146200E-01 |
| Stage1-vs-Stage4 |
9.814600E-01 |
| Stage2-vs-Stage3 |
2.209800E-01 |
| Stage2-vs-Stage4 |
1.651170E-01 |
| Stage3-vs-Stage4 |
8.082400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.597400E-04 |
| Normal-vs-AfricanAmerican |
1.912620E-01 |
| Normal-vs-Asian |
4.118600E-03 |
| Caucasian-vs-AfricanAmerican |
1.453810E-01 |
| Caucasian-vs-Asian |
1.820410E-01 |
| AfricanAmerican-vs-Asian |
3.494000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.076000E-03 |
| Normal-vs-Female |
8.13090000000294E-05 |
| Male-vs-Female |
5.961700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.954000E-02 |
| Normal-vs-Age(41-60Yrs) |
5.048600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.982070E-03 |
| Normal-vs-Age(81-100Yrs) |
7.602000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.064800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.506600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.717770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.248200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.186500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.439900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.446000E-02 |
| Normal-vs-Grade 2 |
8.4257000000032E-05 |
| Normal-vs-Grade 3 |
8.089600E-02 |
| Normal-vs-Grade 4 |
8.796100E-03 |
| Grade 1-vs-Grade 2 |
7.053000E-01 |
| Grade 1-vs-Grade 3 |
1.261840E-01 |
| Grade 1-vs-Grade 4 |
5.529600E-01 |
| Grade 2-vs-Grade 3 |
5.961900E-03 |
| Grade 2-vs-Grade 4 |
6.455800E-01 |
| Grade 3-vs-Grade 4 |
1.175420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.182500E-03 |
| Normal-vs-ccB subtype |
2.607400E-04 |
| ccA subtype-vs-ccB subtype |
3.142000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.816900E-03 |
| Normal-vs-N1 |
8.437000E-03 |
| N0-vs-N1 |
5.103700E-02 |
|
|
